Genetics & Genomics

Bookmark and Share rss email print

Advances in genetics and genomics are being translated into practice every day. Examples include screening, diagnosis, treatment, pharmacogenomics and lifestyle choices. An understanding of the ethical challenges encountered by those receiving genetic and genomic-based health care is an essential competency for all nurses. Look here for resources that address current and emerging topics in the expanding use of genomics, cutting edge research, and developments in policy.

Current Publications

ANA and the International Society of Nurses in Genetics are Pleased to Announce a New Publication

Essential Genetic and Genomic Competencies for Nurses With Graduate Degrees

Essential Genetic and Genomic Competencies for Nurses With Graduate Degrees

Published March 2012

Diffusion and Use of Genomic Innovations in Health and Medicine - Workshop SummaryThis link opens up a new window.

Released: June 19, 2008 - The Institute of Medicine’s Roundtable on Translating Genomic-Based Research for Health, established in 2007, held its first workshop to address the following questions: (1) Are there different pathways by which new scientific findings move from the research setting into health care? (2) If so, what are the implications of those different pathways for genomics? (3) What can we learn from the translation of other new technologies as we seek to understand the translation of genome science into health care?

Innovations in Service Delivery in the Age of Genomics - Workshop SummaryThis link opens up a new window.

Released: May 13, 2009-New discoveries in genomics—that is, the study of the entire human genome—are changing how we diagnose and treat diseases. As the trend shifts from genetic testing largely being undertaken for rare genetic disorders to, increasingly, individuals being screened for common diseases, general practitioners, pediatricians, obstetricians/gynecologists, and other providers need to be knowledgeable about and comfortable using genetic information to improve their patients’ health.

Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health - Workshop SummaryThis link opens up a new window.

Released: November 11, 2009-The correlation between genetic variations and variations in disease risk has been a subject of study for more than 100 years. Initially, research focused on single genes that give rise to rare genetic diseases such as cystic fibrosis or Huntington’s disease. With new studies, however, numerous associations have been found between genes and more common diseases, for example breast cancer, type II diabetes, coronary artery disease, asthma, and bipolar disorder. This rapidly advancing field of genomics has stirred great interest in “personalized” health care. The hope is that using genomic information in care will lead to reduced health care costs and improved health results, as preventive measures and treatments are tailored to patients’ genetic susceptibilities. On February 12, 2009, the Institute of Medicine’s Roundtable on Translating Genomic-Based Research for Health hosted a workshop to examine how to evaluate the clinical use of genomic information and the impact of genetic information in caring for patients.

The Value of Genetic and Genomic Technologies - Workshop SummaryThis link opens up a new window.

Released: August 23, 2010-Knowing one’s genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM’s Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice.

Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research - Workshop SummaryThis link opens up a new window.

Released: September 8, 2010 - Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research.

Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development - Workshop SummaryThis link opens up a new window.

Released: December 16, 2010 - Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts.

Generating Evidence for Genomic Diagnostic Test Development This link opens up a new window.

May 6, 2011?Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person’s response to certain drugs, estimate the risk of developing Alzheimer’s disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients’ health.

Ethical and policy issues in pediatric geneticsThis link opens up a new window.
Ethical issues with genetic testing in pediatricsThis link opens up a new window.
Ethical concerns related to pediatric participation in genetic researchThis link opens up a new window.
Essentials of Genetic and Genomic Nursing: Competencies, Curricula Guidelines, and Outcome Indicators, 2nd Edition
Genetics and Genomics Nursing: Scope and Standards of PracticeThis link opens up a new window.

Also Available as an E-Book

Ethics Activities

ANA Gives Testimony to the FDA Molecular and Clincial Testing Advisory Committee

March 8, 2011

ANA at the Table

ANA speaks on "Translating Genomic-Based Research for Health."

From: 
Email:  
To: 
Email:  
Subject: 
Message: